Reply To: Promoting Voluntary Vaccination

It appears that Astro-Zenica has called time out on submission of its Phase 3 test results to CDC for an EUA. Late today, the CEO acknowledged that many researchers have raised legitimate questions about the validity of those results showing the experimental vaccine was 90% effective in a sub-group of trial participants who, by error initially, received a half dose followed by a full dose. Instead, they will perform another study on an accelerated basis across a wide spectrum of participants to remove any doubts regarding efficacy. This still leaves two vaccines (Pfizer and Moderna) whose results the FDA committee will review next week.
In a world of vaccine skeptics, the AZ decision was the prudent way to proceed. Hopefully, the WH will not force a subset of those seeking a vaccination to first be inoculated against TDS.